FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Imbalances in Brain Microbiota May Be Behind Demyelination in MS, Study Says


























Alterations in microorganisms in the brains of MS patients could contribute to underlying disease mechanisms, including demyelination, according to researchers.

The study, “Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis,” was published in the journal Scientific Reports.

It is widely recognized that the balance of resident microorganisms (the microbiota) in different tissues is important to both health and disease. Imbalances in organ-specific microbiota are commonly associated with .

In MS, inflammatory damage to myelin, the protective layer covering nerve fibers in the brain and spinal cord, affects the white matter, inducing characteristic MS symptoms. But it is still not clear why such demyelination happens. Some studies have shown that, in part, bacteria may cause this process.

Researchers here investigated bacterial quantity and genetic diversity in autopsy brain samples from patients with MS, and compared them with age- and sex-matched samples from people without MS, which served as controls.

Tested samples of  white matter presented low bacterial burden and replication, compared to active bacterial infections in other tissues, they reported. This is, however, not surprising given the sensitivity of the brain to invaders like bacteria and its defenses.

After identifying the microbiota present in all samples, researchers found that a particular group of bacteria, known as Proteobacteria, was more common in white matter samples from MS patients compared to those from non-MS individuals.

In-depth analysis of the bacterial genetic information revealed a “restricted diversity” of Proteobacteria in white matter samples of progressive MS patients, that was linked with increased inflammatory gene expression. Samples from relapsing-remitting MS patients showed a relatively broader range of bacterial species.

Researchers also found that the presence and type of bacteria in the brain was associated with host immune response. Importantly, the detection of a specific bacterial protein, called bacterial peptidoglycan (PGN), correlated with demyelination and neuroinflammation in MS brain samples, which may help to explain disease development and progression.

The team also found that PGN accumulated within demyelinating MS lesions in response to the host immune system. Inflammatory demyelination, they concluded, can be associated to a tissue-specific dysbiosis (microbiota imbalance) in MS.

Principal component analysis revealed that demyelination,  and inflammatory gene expression accounted for 86% of the observed variance,” the researchers wrote. “Thus, inflammatory demyelination is linked to an organ-specific dysbiosis in MS that could contribute to underlying disease mechanisms.”

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News